Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating disease, which mainly
caused by the rupture of an intracranial aneurysm. Clinical trials have demonstrated that …

Subarachnoid hemorrhage (SAH) can lead to devastating neurological outcomes, and there
are few pharmacologic treatments available for treating this condition. Both animal and …

BACKGROUND: Delayed vasospasm is the leading cause of morbidity and mortality after
aneurysmal subarachnoid hemorrhage (aSAH). This phenomenon was first described more …

Aneurysmal subarachnoid hemorrhage (aSAH) remains a leading cause of morbidity and
mortality in patients who survive the initial ictus, primarily as a result of the development of …

All forms of cerebral inflammation as found in bacterial meningitis, cerebral malaria, brain
injury, and subarachnoid haemorrhage have been associated with vasospasm of cerebral …

Leukocyte-endothelial cell interactions appear to be the root cause of chronic vasospasm
after aneurysmal subarachnoid hemorrhage (aSAH). Early clinical observations and indirect …

Cerebral vasospasm (CVS) is a potentially lethal complication of aneurysmal subarachnoid
hemorrhage (aSAH). Recently, the symptomatic presentation of CVS has been termed …

METHODS: Wild-type Hp 1-1 C57Bl/6J mice (n= 45) and genetically modified Hp 2-2
C57Bl/6J mice (n= 45), underwent injection of either autologous blood or normal saline into …

Subarachnoid hemorrhage (SAH) is a devastating neurological injury associated with
significant patient morbidity and death. Since the first demonstration of cerebral vasospasm …

PD-1+ Monocytes Mediate Cerebral Vasospasm Following Subarac... : Neurosurgery PD-1+
Monocytes Mediate Cerebral Vasospasm Following Subarachnoid Hemorrhage : Neurosurgery …